What companies are PBE's competitors?

Invesco Biotechnology & Genome ETF (PBE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does PBE compare to its peers?

The peer comparison table on this page shows Invesco Biotechnology & Genome ETF (PBE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does PBE operate in?

Invesco Biotechnology & Genome ETF (PBE) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

PBE

Invesco Biotechnology & Genome ETF

AMEX·Asset Management · Financial Services

$95.65$2.28+2.44%

After hours·$95.67+0.03%

Market cap$291.60M·Market closed·Sep 17 7:59 PM UTC

Frequently Asked Questions About PBE

What companies are PBE's competitors?: Invesco Biotechnology & Genome ETF (PBE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does PBE compare to its peers?: The peer comparison table on this page shows Invesco Biotechnology & Genome ETF (PBE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does PBE operate in?: Invesco Biotechnology & Genome ETF (PBE) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

PBE

Invesco Biotechnology & Genome ETF

AMEX·Asset Management · Financial Services

$95.65$2.28+2.44%

After hours·$95.67+0.03%

Market cap$291.60M·Market closed·Sep 17 7:59 PM UTC

Peers


CLSE	Convergence Long/Short Equity ETF	$34.12	$394.7M
JSML	Janus Henderson Small Cap Growth Alpha ETF	$86.29	$358.3M
DEXC	Dimensional - Emerging Markets ex China Core Equity ETF	$78.31	$352.0M
AVSD	Avantis Responsible International Equity ETF	$80.01	$348.1M
ISMD	Inspire Small/Mid Cap ETF	$47.24	$302.9M
RSPD	Invesco S&P 500 Equal Weight Consumer Discretionary ETF	$52.72	$286.0M
IQSI	NYLI Candriam International Equity ETF	$38.29	$258.5M
EDOW	First Trust Dow 30 Equal Weight ETF	$45.11	$240.5M
VSDA	VictoryShares Dividend Accelerator ETF	$57.41	$235.2M
RSPS	Invesco S&P 500 Equal Weight Consumer Staples ETF	$29.96	$232.8M

Frequently Asked Questions About PBE

What companies are PBE's competitors?: Invesco Biotechnology & Genome ETF (PBE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does PBE compare to its peers?: The peer comparison table on this page shows Invesco Biotechnology & Genome ETF (PBE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does PBE operate in?: Invesco Biotechnology & Genome ETF (PBE) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.